Obsidio

Obsidio, Inc. is an early-stage medical device company dedicated to developing minimally invasive occlusion agents using shear-thinning biomaterials (STB) technology, which can be used to control bleeding, seal blood vessels supplying tumors, eliminate abnormal connections between arteries and veins, and treat aneurysms.